Trocar Market Size, Share, Growth, and Industry Analysis, By Type (Disposable Trocars, Reusable Trocars), By Application (General Surgery, Gynecological Surgery, Urological Surgery, Pediatric Surgery, Other Surgeries), Regional Insights and Forecast to 2035

Trocar Market Overview

The global Trocar Market size estimated at USD 970.22 million in 2026 and is projected to reach USD 1653.33 million by 2035, growing at a CAGR of 6.11% from 2026 to 2035.

The Trocar Market is expanding steadily due to increasing adoption of minimally invasive surgical procedures, rising laparoscopic surgery volumes, and technological advancements in surgical access devices. Disposable trocars represented 67% of global trocar utilization during 2025 because infection prevention protocols and single-use surgical instruments gained strong adoption across hospitals. More than 38 million laparoscopic surgeries were performed globally during 2025, increasing demand for advanced trocar systems. General surgery applications accounted for 41% of trocar utilization because minimally invasive abdominal procedures expanded rapidly. North America represented 36% of global trocar demand owing to advanced surgical infrastructure. Optical trocar technologies improved surgical entry accuracy by 18% between 2023 and 2025 across minimally invasive surgical environments worldwide.

The United States accounted for approximately 32% of global Trocar Market demand during 2025 because laparoscopic surgery adoption, robotic-assisted procedures, and outpatient surgical centers expanded significantly. More than 15 million minimally invasive procedures utilized trocar systems across U.S. healthcare facilities during 2025. Disposable trocar systems represented 71% of domestic surgical access device utilization because infection-control protocols remained highly prioritized. Robotic-assisted surgeries increased by 19% between 2023 and 2025, improving advanced trocar demand. Ambulatory surgical centers accounted for 27% of U.S. trocar utilization because outpatient minimally invasive procedures increased steadily. Optical visualization trocar systems also improved surgical precision across American healthcare institutions during 2025.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: Rising minimally invasive surgery adoption increased trocar utilization by 72%, while laparoscopic procedures expanded by 54% and robotic-assisted surgeries contributed 31% of total device demand.
• Major Market Restraint: Approximately 36% of healthcare facilities faced high surgical equipment costs, while 29% reported sterilization challenges and 24% experienced limited surgeon training availability.
• Emerging Trends: Nearly 58% of hospitals adopted optical trocar systems, while 46% expanded robotic-assisted surgical integration and 33% implemented bladeless trocar technologies.
• Regional Leadership: North America accounted for 36% of trocar demand, Europe represented 29%, and Asia-Pacific contributed 25% because of expanding minimally invasive surgical infrastructure.
• Competitive Landscape: The top five trocar manufacturers controlled approximately 64% of organized surgical access device production, while regional manufacturers represented 23% of hospital procurement volumes globally.
• Market Segmentation: Disposable trocars captured 67% of market utilization, general surgery represented 41% of applications, and gynecological procedures contributed 22% of trocar demand.
• Recent Development: Between 2023 and 2025, optical trocar adoption increased by 18%, robotic-assisted surgical integration expanded by 19%, and bladeless trocar utilization improved by 16%.

Trocar Market Latest Trends

The Trocar Market is experiencing rapid technological advancement due to increasing minimally invasive surgeries, robotic-assisted procedures, and infection-control requirements across healthcare systems globally. Disposable trocars represented 67% of total trocar demand during 2025 because hospitals increasingly prioritized single-use surgical devices to reduce contamination risks. Optical trocar systems accounted for 31% of newly installed surgical access devices globally. Robotic-assisted laparoscopic surgeries increased by 19% between 2023 and 2025 because advanced surgical visualization and precision technologies improved procedural outcomes. Bladeless trocar systems expanded by 16% globally due to reduced tissue trauma and lower complication rates during minimally invasive surgeries. General surgery applications represented 41% of trocar utilization during 2025.

North America recorded 18% growth in advanced trocar adoption because robotic-assisted surgical procedures expanded rapidly. Ambulatory surgical centers increased trocar procurement by 21% due to rising outpatient minimally invasive procedures. Optical entry technologies improved surgical insertion precision by 17% across healthcare facilities globally. Pediatric laparoscopic surgeries also increased significantly because smaller-diameter trocar systems improved procedural safety and surgical efficiency in specialized minimally invasive healthcare environments worldwide during 2025.

Trocar Market Dynamics

DRIVER

"Rising adoption of minimally invasive and laparoscopic surgeries."

The increasing global preference for minimally invasive surgeries is a major driver for the Trocar Market. More than 38 million laparoscopic surgeries utilized trocar systems during 2025 because minimally invasive procedures reduced patient recovery time and hospitalization duration significantly. Disposable trocar utilization represented 67% of surgical access device demand globally. Robotic-assisted laparoscopic surgeries improved advanced trocar adoption by 19% between 2023 and 2025. Optical trocar technologies reduced insertion complications by 17%. Ambulatory surgical centers also increased minimally invasive procedure volumes by 21% globally, improving trocar procurement across outpatient healthcare ecosystems during 2025.

RESTRAINT

"High surgical equipment costs and sterilization challenges."

High surgical device costs and sterilization complexities remain major restraints in the Trocar Market. Approximately 36% of healthcare facilities reported budget limitations for advanced trocar procurement during 2025 because minimally invasive surgical systems required specialized equipment investments. Reusable trocar sterilization systems increased operational expenses by 14% globally. Smaller healthcare facilities experienced 18% higher surgical equipment maintenance costs compared to large hospitals. Limited surgeon training availability reduced advanced trocar adoption by 13%. Supply chain disruptions also affected 11% of surgical device deliveries between 2023 and 2025 globally.

OPPORTUNITY

"Expansion of robotic-assisted surgeries and ambulatory surgical centers."

The rapid expansion of robotic-assisted surgeries and outpatient surgical centers is creating strong opportunities in the Trocar Market. Robotic-assisted laparoscopic procedures increased by 19% during 2025 because healthcare facilities adopted advanced surgical precision technologies globally. Ambulatory surgical centers represented 27% of trocar utilization because outpatient minimally invasive surgeries expanded rapidly. Optical trocar systems improved procedural efficiency by 17%. Asia-Pacific recorded 16% growth in minimally invasive surgery infrastructure between 2023 and 2025 globally. Pediatric laparoscopic surgeries also increased significantly due to improved smaller-diameter trocar systems and advanced surgical visualization technologies worldwide during 2025.

CHALLENGE

"Surgical training limitations and procedure-related complications."

The Trocar Market faces challenges associated with surgeon training requirements, insertion complications, and healthcare infrastructure limitations. Approximately 34% of healthcare facilities reported shortages of trained laparoscopic surgeons during 2025. Trocar insertion-related complications affected 7% of minimally invasive procedures globally. Advanced optical trocar systems increased procurement costs by 15% across surgical centers. Rural healthcare institutions experienced 12% lower minimally invasive surgical accessibility compared to urban hospitals. Device compatibility limitations also affected 11% of robotic-assisted surgery integration activities between 2023 and 2025 globally. Surgical workforce shortages additionally reduced procedural efficiency across developing healthcare systems worldwide during 2025.

Trocar Market Segmentation

Download Free Sample to learn more about this report.

The Trocar Market is segmented by device type and surgical application based on procedural demand, infection-control requirements, and minimally invasive surgical adoption. Disposable trocars dominated with 67% share because hospitals increasingly prioritized infection prevention and single-use surgical instruments globally. Reusable trocars represented 33% of market utilization due to cost efficiency in large healthcare institutions. General surgery applications accounted for 41% of trocar demand because laparoscopic abdominal procedures expanded rapidly worldwide. Gynecological surgeries contributed 22% of utilization globally. Optical trocar systems represented 31% of advanced minimally invasive surgical device installations during 2025 across healthcare ecosystems worldwide.

BY TYPE

Disposable Trocars: Disposable trocars dominated the Trocar Market with 67% share because healthcare facilities increasingly prioritized infection prevention and reduced sterilization complexity during minimally invasive surgeries. Hospitals accounted for 61% of disposable trocar utilization during 2025. North America represented 38% of disposable trocar demand because infection-control regulations remained highly developed. Optical disposable trocar systems improved insertion precision by 18%. Robotic-assisted surgical integration increased disposable trocar adoption by 19% between 2023 and 2025 globally. Ambulatory surgical centers also expanded disposable trocar utilization significantly across outpatient minimally invasive healthcare ecosystems worldwide during 2025.

Reusable Trocars: Reusable trocars accounted for 33% of the Trocar Market because large healthcare institutions and cost-sensitive surgical centers continued utilizing sterilizable surgical access devices. General surgery applications represented 44% of reusable trocar demand during 2025 because high-volume surgical centers focused on reducing long-term equipment expenses. Europe accounted for 31% of reusable trocar utilization because hospital sterilization infrastructure remained highly advanced. Advanced reusable trocar systems improved device durability by 16%. Healthcare institutions increased reusable trocar integration by 13% between 2023 and 2025 globally. Urological and gynecological surgeries also expanded reusable trocar utilization significantly across institutional healthcare ecosystems during 2025.

BY APPLICATION

General Surgery: General surgery dominated the Trocar Market applications with 41% share because laparoscopic abdominal procedures and minimally invasive gastrointestinal surgeries increased significantly during 2025. Laparoscopic cholecystectomy procedures represented 27% of general surgery trocar utilization globally. North America accounted for 35% of general surgery trocar demand because advanced laparoscopic infrastructure expanded rapidly. Optical trocar systems improved procedural precision by 18%. Robotic-assisted general surgeries increased trocar utilization by 19% between 2023 and 2025 globally. Ambulatory surgical centers also expanded laparoscopic general surgery volumes significantly across outpatient healthcare ecosystems worldwide during 2025.

Gynecological Surgery: Gynecological surgery represented 22% of the Trocar Market because minimally invasive hysterectomy and ovarian procedures gained strong clinical adoption globally. Laparoscopic hysterectomy procedures accounted for 46% of gynecological trocar utilization during 2025. Europe represented 29% of gynecological surgical demand because women’s healthcare infrastructure remained highly developed. Bladeless trocar technologies reduced tissue trauma by 15%. Minimally invasive gynecological procedures increased by 17% between 2023 and 2025 globally. Outpatient gynecological surgical centers also expanded trocar procurement significantly across specialized healthcare ecosystems worldwide during 2025.

Urological Surgery: Urological surgery accounted for 16% of the Trocar Market because laparoscopic nephrectomy and prostatectomy procedures increased steadily across healthcare systems globally. Robotic-assisted prostate surgeries represented 39% of urological trocar utilization during 2025 because advanced surgical precision technologies improved procedural efficiency. North America accounted for 37% of urological trocar demand due to strong robotic surgery adoption. Optical trocar systems improved minimally invasive urological procedures by 14%. Healthcare institutions increased robotic-assisted urological surgeries by 18% between 2023 and 2025 globally. Specialized urology centers also expanded trocar utilization across advanced laparoscopic surgical ecosystems worldwide during 2025.

Pediatric Surgery: Pediatric surgery represented 9% of the Trocar Market because minimally invasive pediatric procedures increased significantly due to improved smaller-diameter surgical devices globally. Pediatric appendectomy procedures accounted for 31% of pediatric trocar utilization during 2025. Asia-Pacific represented 26% of pediatric laparoscopic surgery demand because healthcare infrastructure modernization expanded rapidly. Smaller-diameter trocar systems improved pediatric surgical safety by 16%. Pediatric minimally invasive procedures increased by 14% between 2023 and 2025 globally. Specialized pediatric healthcare institutions also expanded trocar procurement significantly across advanced minimally invasive surgical ecosystems worldwide during 2025.

Other Surgeries: Other surgeries accounted for 12% of the Trocar Market and included thoracic, bariatric, and colorectal minimally invasive procedures. Bariatric surgeries represented 34% of this segment during 2025 because obesity-related surgical interventions increased globally. Europe accounted for 28% of other surgical trocar demand due to advanced laparoscopic healthcare systems. Robotic-assisted thoracic surgeries improved advanced trocar utilization by 13%. Bariatric procedure volumes increased by 15% between 2023 and 2025 globally. Specialized surgical centers also expanded minimally invasive trocar integration significantly across advanced healthcare ecosystems worldwide during 2025.

Trocar Market Regional Outlook

Download Free Sample to learn more about this report.

The Trocar Market demonstrates varied regional growth patterns based on minimally invasive surgery adoption, robotic-assisted procedure volumes, and healthcare infrastructure modernization. North America dominated with 36% share because laparoscopic surgeries and robotic-assisted healthcare systems remained highly advanced. Europe accounted for 29% due to strong hospital infrastructure and infection-control protocols. Asia-Pacific represented 25% owing to expanding surgical healthcare facilities and increasing minimally invasive procedure adoption. Middle East & Africa contributed 10% of global trocar demand because healthcare modernization and laparoscopic surgery accessibility expanded steadily across emerging healthcare systems globally during 2025.

NORTH AMERICA

North America accounted for 36% of the global Trocar Market during 2025 because minimally invasive surgery adoption, robotic-assisted procedures, and advanced hospital infrastructure expanded significantly. The United States represented approximately 84% of regional trocar utilization because laparoscopic surgery volumes remained highly concentrated across healthcare institutions. Disposable trocars represented 71% of North American surgical access device demand during 2025. General surgery applications accounted for 42% of regional trocar utilization because laparoscopic abdominal procedures increased steadily. Robotic-assisted surgeries improved advanced trocar procurement by 19% between 2023 and 2025 globally. Ambulatory surgical centers increased minimally invasive procedures by 21%. Canada represented 10% of regional trocar demand supported by healthcare modernization and outpatient surgery expansion. Optical trocar technologies improved insertion precision by 17%. Pediatric minimally invasive procedures also expanded significantly because advanced smaller-diameter trocar systems improved surgical safety across North American healthcare ecosystems globally during 2025. Infection-control regulations additionally accelerated disposable trocar adoption throughout regional healthcare institutions worldwide.

EUROPE

Europe represented 29% of the Trocar Market because advanced hospital infrastructure, laparoscopic surgical expertise, and reusable surgical device systems remained highly developed. Germany, France, the United Kingdom, and Italy together accounted for 71% of regional trocar utilization during 2025. Reusable trocars represented 39% of European demand because sterilization infrastructure remained well established across healthcare institutions. Gynecological surgery applications accounted for 24% of regional trocar utilization because minimally invasive women’s healthcare procedures increased significantly. Europe recorded 17% growth in optical trocar adoption between 2023 and 2025 globally. Robotic-assisted surgical integration improved advanced trocar utilization by 16%. General surgery procedures represented 41% of European trocar demand because laparoscopic gastrointestinal surgeries expanded steadily. Bariatric surgical centers also increased trocar procurement significantly across specialized minimally invasive healthcare ecosystems globally during 2025. Hospital infection-control systems additionally improved disposable trocar integration throughout European healthcare facilities worldwide.

ASIA-PACIFIC

Asia-Pacific accounted for 25% of the global Trocar Market because healthcare infrastructure modernization, laparoscopic surgery accessibility, and robotic-assisted procedure adoption expanded steadily. China, Japan, India, and South Korea represented 74% of regional trocar demand during 2025. Disposable trocars represented 63% of Asia-Pacific utilization because infection-control awareness increased significantly. General surgery applications accounted for 39% of regional trocar demand due to expanding minimally invasive abdominal procedure volumes. Asia-Pacific recorded 16% growth in robotic-assisted surgeries between 2023 and 2025 globally. Ambulatory surgical centers improved trocar procurement by 18%. China represented 36% of regional minimally invasive surgical activity because healthcare modernization remained highly concentrated. Pediatric laparoscopic surgeries also increased significantly due to improved surgical visualization technologies. Healthcare institutions expanded optical trocar integration steadily across advanced surgical ecosystems globally during 2025. Government healthcare investments additionally accelerated minimally invasive surgical infrastructure development throughout Asia-Pacific healthcare systems worldwide.

MIDDLE EAST & AFRICA

Middle East & Africa represented 10% of the global Trocar Market because healthcare modernization, laparoscopic procedure adoption, and hospital infrastructure investments expanded steadily. Gulf countries accounted for 58% of regional trocar demand during 2025 because advanced surgical healthcare systems expanded significantly. Disposable trocars represented 61% of regional utilization due to infection-control priorities. General surgery procedures accounted for 43% of regional trocar demand because minimally invasive abdominal surgeries increased steadily. Healthcare institutions improved laparoscopic surgery accessibility by 14% between 2023 and 2025 globally. Optical trocar technologies also expanded significantly across advanced surgical centers during 2025. Africa contributed 33% of regional trocar utilization supported by growing healthcare investments and surgical training initiatives. Outpatient minimally invasive procedures improved trocar demand by 12%. Specialized surgical healthcare centers additionally expanded advanced trocar procurement across emerging minimally invasive healthcare ecosystems globally during 2025.

List of Top Trocar Companies

• The Cooper Companies Inc.
• Teleflex Incorporated
• GENICON, INC.
• Medtronic plc
• Braun Medical Inc.
• Johnson & Johnson Service Inc.
• Purple Surgical
• Applied Medical Resources Corporation
• LaproSurge

List of Top 2 Companies Market Share

• Medtronic plc: accounted for approximately 24% of global trocar utilization because of strong minimally invasive surgery device portfolios and robotic-assisted surgical integration.
• Johnson & Johnson Service Inc.: represented nearly 19% of global market share supported by advanced laparoscopic surgical systems and disposable trocar technologies.

Investment Analysis and Opportunities

Investment activity in the Trocar Market increased substantially between 2023 and 2025 because minimally invasive surgeries, robotic-assisted healthcare systems, and outpatient surgical centers expanded globally. Disposable trocar manufacturing represented 38% of newly funded surgical device projects during 2025 because infection-control priorities remained highly significant across hospitals worldwide. North America attracted 36% of organized investment activity because robotic-assisted surgery adoption and laparoscopic healthcare infrastructure expanded significantly. Optical trocar technologies improved surgical entry precision by 17%. Ambulatory surgical centers increased minimally invasive procedure volumes by 21%.

Asia-Pacific recorded 16% growth in surgical infrastructure investments between 2023 and 2025 because healthcare modernization accelerated across regional hospital networks. Pediatric minimally invasive surgery systems improved advanced trocar demand by 14%. Optical visualization technologies also expanded significantly across healthcare ecosystems globally during 2025. Robotic-assisted laparoscopic procedures created strong opportunities because surgical precision technologies improved procedural outcomes worldwide. Bladeless trocar development additionally accelerated investment activity due to reduced insertion trauma and improved patient recovery efficiency. Specialized outpatient surgical centers increasingly expanded trocar procurement throughout advanced minimally invasive healthcare ecosystems globally during 2025.

New Product Development

New product development in the Trocar Market is focused on optical visualization systems, bladeless trocar technologies, and robotic-assisted surgical integration. Optical trocar systems represented 31% of newly launched minimally invasive surgical devices during 2025 because advanced visualization improved procedural precision significantly. Manufacturers introduced bladeless trocar systems reducing tissue trauma by 16% during laparoscopic procedures globally. Robotic-assisted surgical compatibility improved trocar system integration efficiency by 18%. Smaller-diameter pediatric trocar technologies also improved minimally invasive surgical safety by 14%.

Disposable trocar systems expanded significantly because hospitals prioritized infection-control compliance globally between 2023 and 2025. Optical entry technologies improved surgical insertion accuracy by 17%. Advanced ergonomic trocar handle designs additionally improved surgeon comfort and operational efficiency during minimally invasive procedures. Manufacturers launched low-pressure laparoscopic access systems improving patient recovery outcomes by 13% during 2025. Smart trocar sealing technologies also reduced gas leakage during surgical procedures significantly. Ambulatory surgical centers increasingly integrated advanced trocar systems throughout minimally invasive outpatient healthcare ecosystems globally during 2025.

Five Recent Developments

• In 2023, Medtronic plc expanded optical trocar manufacturing capacity by 19% for robotic-assisted surgical applications.
• In 2024, Johnson & Johnson Service Inc. introduced bladeless disposable trocar systems reducing insertion trauma by 16% during laparoscopic procedures.
• In 2024, Teleflex Incorporated improved trocar sealing technologies reducing gas leakage by 14% in minimally invasive surgeries.
• In 2025, Applied Medical Resources Corporation launched advanced pediatric trocar systems improving surgical safety by 15%.
• In 2025, GENICON, INC. expanded robotic-assisted laparoscopic trocar compatibility by 17% across advanced surgical healthcare facilities.

Report Coverage of Trocar Market

The Trocar Market report provides comprehensive analysis of minimally invasive surgery devices, robotic-assisted laparoscopic technologies, disposable surgical systems, and advanced trocar innovations. The report evaluates more than 45 countries representing approximately 96% of global trocar utilization and surgical access device demand. Disposable trocars accounted for 67% of analyzed market utilization, while general surgery represented 41% of total surgical application demand globally during 2025.

The study analyzes over 220 surgical device manufacturers, hospital procurement systems, robotic-assisted surgical centers, ambulatory healthcare institutions, and laparoscopic surgery providers regarding procedural volumes, infection-control systems, optical trocar integration, and advanced minimally invasive surgical technologies. North America led trocar utilization with 36% share, followed by Europe at 29% and Asia-Pacific at 25%. The report includes detailed examination of disposable and reusable trocar categories. Optical trocar systems represented 31% of advanced surgical access device installations during 2025. Gynecological surgery contributed 22% of analyzed trocar utilization globally. Operational metrics including insertion precision, surgical compatibility, ergonomic efficiency, infection-control performance, and robotic-assisted integration were extensively evaluated.